Literature DB >> 29879269

The Value of Neoadjuvant Chemotherapy in Localized High-Risk Soft-Tissue Sarcoma of the Extremities and Trunk.

Alessandro Gronchi1, Robin L Jones2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29879269     DOI： 10.1001/jamaoncol.2018.1392

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  3 in total

1.  Chemotherapy improves distant control in localized high-grade soft tissue sarcoma of the extremity/trunk.

Authors:  Victoria T Rizk; Arash O Naghavi; Andrew S Brohl; David M Joyce; Odion Binitie; Youngchul Kim; John P Hanna; Jennifer Swank; Ricardo J Gonzalez; Damon R Reed; Mihaela Druta
Journal:  Clin Sarcoma Res       Date:  2020-07-09

2.  Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups.

Authors:  Alessandro Gronchi; Nadia Hindi; Josefina Cruz; Jean-Yves Blay; Antonio Lopez-Pousa; Antoine Italiano; Rosa Alvarez; Antonio Gutierrez; Inmaculada Rincón; Claudia Sangalli; Jose Luis Pérez Aguiar; Jesús Romero; Carlo Morosi; Marie Pierre Sunyach; Roberta Sanfilippo; Cleofe Romagosa; Dominique Ranchere-Vince; Angelo P Dei Tos; Paolo G Casali; Javier Martin-Broto
Journal:  EClinicalMedicine       Date:  2019-03-11

3.  Apatinib with doxorubicin and ifosfamide as neoadjuvant therapy for high-risk soft tissue sarcomas: a retrospective cohort study.

Authors:  Zhichao Tian; Jiaqiang Wang; Jinpo Yang; Peng Zhang; Xin Wang; Fan Zhang; Po Li; Weitao Yao
Journal:  Invest New Drugs       Date:  2021-06-22       Impact factor: 3.850
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.